NEUROENDOCRINE CARCINOMA (NEC)

Clinical trials for NEUROENDOCRINE CARCINOMA (NEC) explained in plain language.

Never miss a new study

Get alerted when new NEUROENDOCRINE CARCINOMA (NEC) trials appear

Sign up with your email to follow new studies for NEUROENDOCRINE CARCINOMA (NEC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New drug trial opens for patients with advanced cancers

Disease control Recruiting now

This is an early-stage study testing a new drug called MT-4561 in people with various advanced solid tumors who have run out of standard treatment options. The main goals are to find a safe dose, see how the body processes the drug, and check for any early signs that it might hel…

Matched conditions: NEUROENDOCRINE CARCINOMA (NEC)

Phase: PHASE1, PHASE2 • Sponsor: Tanabe Pharma America, Inc. • Aim: Disease control

Last updated Apr 01, 2026 14:41 UTC

NEUROENDOCRINE CARCINOMA (NEC)

Get alerted when new NEUROENDOCRINE CARCINOMA (NEC) trials appear

New drug trial opens for patients with advanced cancers